Publications by authors named "SANTI D"

Purpose: Infertility is defined as the inability to conceive after 1 year of unprotected intercourse, affecting approximately 15-20% of couples in Western countries. It is a shared problem within the couple; when the main issue lies with one of the partners, it is preferable to refer to "male factor" or "female factor" infertility rather than simply male or female infertility. Despite male factor infertility accounting for half of all couple infertility cases, the clinical approach to the male partner is not uniformly standardized across international guidelines.

View Article and Find Full Text PDF

Over the past 40-50 years, demographic shifts and the obesity epidemic have coincided with significant changes in lifestyle habits, including a rise in excessive alcohol consumption. This increase in alcohol intake is a major public health concern due to its far-reaching effects on human health, particularly on metabolic processes and male reproductive function. This narrative review focuses on the role of alcohol consumption in altering metabolism and impairing testicular function, emphasizing the potential damage associated with both acute and chronic alcohol intake.

View Article and Find Full Text PDF
Article Synopsis
  • IL-15 agonists are promising immunotherapy options as they boost the growth of immune cells like natural killer (NK) and CD8 T cells, but they have a short duration in the body requiring frequent doses.
  • A new approach using hydrogel microspheres (MS) was developed to extend the half-life of IL-15, which successfully increased its duration to about one week.
  • The study found that the MS conjugate of another IL-15 agonist, RLI, had a shorter half-life of 30 hours and was effective in stimulating immune cells, but caused significant injection-site toxicity; thus, it was focused on for intra-tumoral therapy where such effects could be potentially beneficial.
View Article and Find Full Text PDF

The objective of this work was to develop a long-acting form of the lipidated peptide semaglutide that can be administered to humans once-monthly. Semaglutide was attached to hydrogel microspheres by a cleavable linker with an expected in vivo release half-life of about 1 mo. After a single subcutaneous dose, the pharmacokinetic parameters of released semaglutide and bodyweight loss were determined in mice, and results were used to estimate the dosing and pharmacokinetics of the released semaglutide in humans.

View Article and Find Full Text PDF
Article Synopsis
  • * A meta-analysis of 12 studies involving 345 obese men showed that weight loss significantly improved sperm concentration and motility, and reduced DNA fragmentation in sperm.
  • * The findings suggest that weight loss could enhance sperm quality, indicating it may be beneficial for obese men experiencing fertility issues during attempts to conceive.
View Article and Find Full Text PDF

The enhanced permeability and retention (EPR) effect controls passive nanodrug uptake in tumors and may provide a high tumor payload with prolonged retention for cancer treatment. However, EPR-mediated tumor uptake and distribution vary by cancer phenotype. Thus, we hypothesized that a companion PET imaging surrogate may benefit EPR-mediated therapeutic drug delivery.

View Article and Find Full Text PDF

Follicle-stimulating hormone (FSH) administration is applied in the management of subjects affected by hypogonadotropic hypogonadism. Whilst this application is widely recognized and established alone or in combination with human chorionic gonadotropin (hCG), a similar strategy is empirically advocated in idiopathic male factor infertility (MFI). In this setting, FSH therapy has been used to increase sperm quantity, quality, and pregnancy rate when FSH plasma concentrations are below 8 IU/L and when the seminal tract is not obstructed.

View Article and Find Full Text PDF
Article Synopsis
  • The review systematically analyzed data on patient and partner satisfaction with penile prosthesis (PP) implantation, showing a high overall satisfaction rate of 83%.
  • Out of 663 articles, 83 were included, covering 12,132 subjects, with findings indicating higher satisfaction linked to three-piece prostheses, certain health conditions, and the use of inflatable devices.
  • Long-term complications were minimal, with rates between 3-4.6%, and satisfaction tended to increase over time, while being higher for patients than partners.
View Article and Find Full Text PDF
Article Synopsis
  • Central nervous system tumors are hard to treat with traditional chemotherapy due to the blood-tumor-brain-barrier, but nanomedicines, particularly those sized between 10 and 100 nm, might offer a solution by accumulating in tumors.
  • The study focuses on PLX038A, a prodrug of the anti-cancer drug SN-38, which effectively inhibited the growth of breast cancer and glioblastoma in mice, leading to increased lifespan.
  • Researchers found that PLX038A penetrates the blood-tumor-brain-barrier, accumulates in tumors, and releases SN-38 from within, suggesting that the PEG carrier used could potentially deliver other treatments into brain tumors as well.
View Article and Find Full Text PDF

Malignant rhabdoid tumors (MRTs) are among the most aggressive and treatment-resistant malignancies affecting infants, originating in the kidney, brain, liver, and soft tissues. The 5-year event-free survival rate for these cancers is a mere 20%. In nearly all cases of MRT, the gene (occasionally )-a pivotal component of the SWI/SNF chromatin remodeling complex-is homozygously deleted, although the precise etiology of these tumors remains unknown.

View Article and Find Full Text PDF

Intratumoral (IT) therapy is a powerful method of controlling tumor growth, but a major unsolved problem is the rapidity that injected drugs exit tumors, limiting on-target exposure and efficacy. We have developed a generic long acting IT delivery system in which a drug is covalently tethered to hydrogel microspheres (MS) by a cleavable linker; upon injection the conjugate forms a depot that slowly releases the drug and "bathes" the tumor for long periods. We established technology to measure tissue pharmacokinetics and studied MSs attached to SN-38, a topoisomerase 1 inhibitor.

View Article and Find Full Text PDF

Objective: Many cases of subacute thyroiditis (SAT) have been described related to SARS-CoV-2 infection, but no prospective data about follow-up are known. This prospective, longitudinal, 3-year, multicentre study aims to explore the clinical peculiarities and outcome of SAT in relation to SARS-CoV-2 infection, ascertained with antibody dosage.

Methods: All patients receiving SAT diagnosis from November 2020 to May 2022 were enrolled.

View Article and Find Full Text PDF

The tumor uptake of large non-targeted nanocarriers primarily occurs through passive extravasation, known as the enhanced permeability and retention (EPR) effect. Prior studies demonstrated improved tumor uptake and retention of 4-arm 40 kDa star polyethylene glycol (StarPEG) polymers for cancer imaging by adding prostate-specific membrane antigen (PSMA) targeting small molecule ligands. To test PSMA-targeted delivery and therapeutic efficacy, StarPEG nanodrugs with/without three copies of PSMA-targeting ligands, ACUPA, are designed and synthesized.

View Article and Find Full Text PDF

Poly(ADP-ribose) polymerase inhibitors (PARPi) have been approved for once or twice daily oral use in the treatment of cancers with BRCA defects. However, for some patients, oral administration of PARPi may be impractical or intolerable, and a long-acting injectable formulation is desirable. We recently developed a long-acting PEGylated PARPi prodrug, PEG∼talazoparib (TLZ), which suppressed the growth of PARPi-sensitive tumors in mice for very long periods.

View Article and Find Full Text PDF

Purpose: To evaluate total testosterone distribution in male idiopathic infertility.

Methods: A retrospective, real-world case-control clinical study was conducted. Cases consisted of men evaluated for couple infertility, specifically those with alterations in semen parameters and normal gonadotropin levels, and after excluding all known causes of male infertility.

View Article and Find Full Text PDF
Article Synopsis
  • Scientists created a new system called 'APHRODITE' to classify different types of male infertility to help improve treatments and advice for doctors and patients.
  • The APHRODITE system was developed by a team of experts, looking at patient information and lab tests like semen analysis to sort men into different groups based on their infertility issues.
  • This system identifies five groups of male infertility to make it easier for doctors and researchers to communicate and ultimately help men have babies more effectively.
View Article and Find Full Text PDF

We previously proposed that sacituzumab govitecan (SG, Trodelvy®) likely acts as a simple prodrug of systemic SN-38 as well as an antibody drug conjugate (ADC). In the present commentary, we assess whether a long-acting SN-38 prodrug, such as PLX038, might be efficacious in SG-resistant patients. We first describe possible mechanisms of action of SG, with new insights on pharmacokinetics and TROP2 receptor occupancy.

View Article and Find Full Text PDF

Multidrug-Resistant Tuberculosis (MDR TB) is a threat for the future control of TB disease. In Indonesia, the success rate of MDR TB patient recovery is still very low, following the still low recovery rate of TB patients. This paper aims to discuss the trial result of message delivery containing knowledge and motivation to the MDR TB sufferers.

View Article and Find Full Text PDF

Although epidemiology shows that both men and woman can experience infertility, the female partner usually experiences most of the diagnostic and therapeutic burden. Thus, management of couple infertility is a unique example of gender inequality. The use of exogenous gonadotropins in assisted reproductive technology (ART) to induce multifollicular growth is well consolidated in women, but the same is not done with the same level of confidence and purpose in infertile men.

View Article and Find Full Text PDF

The gut microbiota (GM) plays a crucial role in human health. The bidirectional interaction between GM and the central nervous system may occur via the microbiota-gut-brain axis, possibly regulating the sleep/wake cycle. Recent reports highlight associations between intestinal dysbiosis and sleep disorders, suggesting that probiotics could ameliorate this condition.

View Article and Find Full Text PDF

Objective: Despite having normal thyroid-stimulating hormone levels, many hypothyroid patients are dissatisfied with the treatment. The primary aim of this study was to evaluate the effect of twice-daily, combination therapy with levothyroxine (LT4) and liothyronine (LT3), at doses adapted according to TSH-level, on peripheral tissues as reflected by sex hormone binding globulin (SHBG) levels in totally thyroidectomized patients. Changes in other tissue markers and quality of life considering DIO2-rs225014 and MCT10-rs17606253 genetic variants were also assessed.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates long-term management of gender-affirming hormone treatment (GAHT) for transgender individuals, focusing on treatment adjustments, safety, and hormonal targets.
  • A large sample of transgender people (AFAB and AMAB) in Italy was monitored from 2005 to 2022, collecting various health data to analyze their GAHT experiences.
  • Findings reveal that transgender AFAB individuals reached hormone treatment goals sooner and more consistently, suggesting AMAB individuals may need more frequent follow-ups to improve their treatment outcomes.
View Article and Find Full Text PDF

Testis stimulation with follicle-stimulating hormone (FSH) is one of the empirical treatments proposed for male idiopathic infertility, although reliable markers to predict its efficacy are still lacking. This study aimed to identify parameters able to predict FSH efficacy in terms of pregnancy achievement. A real-world study was conducted, enrolling idiopathic infertile men treated with FSH 150IU three times weekly.

View Article and Find Full Text PDF